Arkadios Wealth Advisors Sells 338 Shares of Cigna Group $CI

Arkadios Wealth Advisors lowered its stake in Cigna Group (NYSE:CI) by 3.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,800 shares of the health services provider’s stock after selling 338 shares during the period. Arkadios Wealth Advisors’ holdings in Cigna Group were worth $2,909,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of CI. Brighton Jones LLC increased its stake in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after purchasing an additional 318 shares during the last quarter. Ameritas Advisory Services LLC bought a new position in Cigna Group in the first quarter valued at about $907,000. DAVENPORT & Co LLC grew its position in Cigna Group by 11.3% in the first quarter. DAVENPORT & Co LLC now owns 5,774 shares of the health services provider’s stock valued at $1,896,000 after acquiring an additional 588 shares during the last quarter. Aaron Wealth Advisors LLC grew its position in Cigna Group by 48.1% in the first quarter. Aaron Wealth Advisors LLC now owns 2,069 shares of the health services provider’s stock valued at $681,000 after acquiring an additional 672 shares during the last quarter. Finally, Pinnacle Financial Partners Inc grew its position in Cigna Group by 10.6% in the first quarter. Pinnacle Financial Partners Inc now owns 885 shares of the health services provider’s stock valued at $291,000 after acquiring an additional 85 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $300.00, for a total value of $8,557,800.00. Following the transaction, the insider directly owned 25,648 shares in the company, valued at $7,694,400. This trade represents a 52.66% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider directly owned 51,182 shares of the company’s stock, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts have issued reports on the company. Robert W. Baird set a $372.00 target price on Cigna Group in a research report on Thursday, August 14th. The Goldman Sachs Group assumed coverage on Cigna Group in a research report on Tuesday, October 14th. They issued a “buy” rating and a $370.00 target price on the stock. Weiss Ratings reiterated a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Wall Street Zen cut Cigna Group from a “buy” rating to a “hold” rating in a research report on Friday, October 3rd. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $365.00 target price on shares of Cigna Group in a research report on Tuesday, August 26th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $369.89.

Cigna Group Stock Performance

Shares of CI stock opened at $247.11 on Friday. The business’s 50 day simple moving average is $298.38 and its 200 day simple moving average is $306.70. Cigna Group has a one year low of $245.61 and a one year high of $350.00. The stock has a market capitalization of $65.96 billion, a PE ratio of 13.49, a PEG ratio of 0.88 and a beta of 0.45. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business had revenue of $69.57 billion for the quarter, compared to analysts’ expectations of $66.40 billion. During the same period in the prior year, the business posted $7.51 earnings per share. The firm’s revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be issued a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date is Thursday, December 4th. Cigna Group’s dividend payout ratio is presently 32.97%.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.